Emedastine Difumarate Patent Expiration

Emedastine Difumarate is Used for treating allergic conjunctivitis. It was first introduced by Novartis Pharmaceuticals Corp in its drug Emadine on Dec 29, 1997.


Emedastine Difumarate Patents

Given below is the list of patents protecting Emedastine Difumarate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Emadine US5441958 Ophthalmic compositions comprising emedastine and methods for their use Dec 08, 2013

(Expired)

Novartis